• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Reumatol. vol.55 número3

Has 10000 "Rev. Bras. Reumatol. vol.55 número3" found on our website. Below are the top 20 most common "Rev. Bras. Reumatol. vol.55 número3".

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... Demographic data and clinical features in 34 IgAD patients according to the presence of auto antibodies are shown in. Table 2[r] ... See full document

6

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... 13 The diffi- culty in performing daily tasks is one of the main complaints of patients with the disease 14,15 causing restrictions in most of their areas of performance 16 : from simple[r] ... See full document

9

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... We conclude that: 1 – the professionals evaluated feel com- fortable in addressing the most prevalent and low complexity rheumatic diseases; 2 – The knowledge of clinical physicians work[r] ... See full document

5

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... As an extended diffuse impairment of the Achilles tendon was observed in the current case and no grouped tophi were observed as hyperechoic ovoid masses within the tendon or calcified ar[r] ... See full document

4

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... Some patients may respond to the use of methotrexate, as demonstrated in a case report of a 25 year-old woman who had a significant improvement of idiopathic peripheral ulcer- ative kera[r] ... See full document

3

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... ABAT, abatecept; ADA, adalimumab; anti-TNF, tumor necrosis factor blocking drugs; RA, rheumatoid arthritis; apoB/apoA, apolipoprotein B/apolipoprotein A; Str., stroke; CERT, certolizumab[r] ... See full document

29

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... 7 More recently, new criteria were proposed, including: (1) the presence of a clinical diagnosis of biphasic RP; (2) a normal NFC; (3) a physical examination with no findings suggestive [r] ... See full document

8

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... In addition, we recently described a signif- icantly higher PTH concentration in 105 patients affected by autoimmune rheumatic diseases with respect to 1020 controls despite similar plas[r] ... See full document

8

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... At the femoral mid-diaphysis (three-point bending test), the effect of immobilization was very pronounced in RHLI (positive control) group; that is, the immobilized side (right) had sign[r] ... See full document

11

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... However, there was an association between positive anti-topo I, ACA or anti- RNAP III antibodies and the clinical subtype of the disease ( p < 0.001), with the percentage of patients [r] ... See full document

11

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... The aim of this study was to determine the prevalence and factors associated with osteopenia and osteoporosis in women who have undergone bone mineral density test in a specialized servi[r] ... See full document

6

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... In the long term (T24), various baseline variables were predictors of the best IAIC response, the most important of which was “do elbow IAIC” (with a 4.4 times higher chance of success),[r] ... See full document

7

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... Regarding the domains of quality of life, a significant improvement in both groups was demonstrated after the pelvic floor kinesiotherapy sessions, which corroborates the results of prev[r] ... See full document

7

Rev. Bras. Reumatol.  vol.55 número3

Rev. Bras. Reumatol. vol.55 número3

... Results: MHC-I antigens were expressed in the sarcolemma and/or sarcoplasm in 79.4% of PM cases, 62.5% of DM cases, and 27.6% of controls (CD4 expression was observed in 76.5%, 75%, and [r] ... See full document

6

Rev. Bras. Reumatol.  vol.55 número5

Rev. Bras. Reumatol. vol.55 número5

... Therefore, we are fostering a series of changes involving the professionalization of our work, with a reclassification of submitted manuscripts, a greater number of reviewers, and a grea[r] ... See full document

1

Rev. Bras. Reumatol.  vol.55 número6

Rev. Bras. Reumatol. vol.55 número6

... Recently, the use of rituximab in the treatment of patients with ANCA-associated vasculitis in randomized clinical trials showed an important alternative in selected cases, especially pa[r] ... See full document

5

Rev. Bras. Reumatol.  vol.55 número6

Rev. Bras. Reumatol. vol.55 número6

... She was diagnosed with seropositive RA according to the criteria of the 1987 American College of Rheumatology, pre- senting over four criteria (morning stiffness, arthritis of 3 or more [r] ... See full document

3

Rev. Bras. Reumatol.  vol.55 número6

Rev. Bras. Reumatol. vol.55 número6

... sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to TNF alpha antagonists. Rituximab: mechanism of action[r] ... See full document

6

Rev. Bras. Reumatol.  vol.55 número5

Rev. Bras. Reumatol. vol.55 número5

... Estamos agora entre as 10 revistas nacionais de maior impacto, ranqueando- -nos entre as 24 publicac¸ões internacionais da área e somos a primeira na área de reumatologia na América Lati[r] ... See full document

1

Rev. Bras. Reumatol.  vol.55 número5

Rev. Bras. Reumatol. vol.55 número5

... HRQL was measured by Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), and evaluated.. physical, emotional, social and school domains.[r] ... See full document

6

Show all 10000 documents...